Stocks tumbled after President Trump escalated his trade war against the rest of the world. But rather than scooping up ...
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now
President Donald Trump’s exemption of pharmaceuticals from “reciprocal” tariffs limited the declines of biopharma stocks as ...
Global pharma giants establish GCCs in India for digital transformation, leveraging tech talent, political stability, and ...
That's why Veeva Systems should remain a leader in its niche and deliver excellent returns over the long run. It's a top stock to buy and hold for the next two decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results